Back to top of page

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

List of Required Information for Application:

1. Project title

2. Contact information for primary investigator

3. Organization/institution name and address

4. Project summary/abstract

5. Background and significance of the rare disease being studied

6. Objectives and aims of the proposed project

7. Proposed research plan and methodologies

8. Timeline for completion of the project

9. Description of how the project will facilitate clinical trial readiness for rare diseases

10. Discussion of candidate therapeutics or diagnostics that will be investigated

11. Explanation of how biomarkers and clinical outcome assessment measures will be developed and tested

12. Description of how the project will contribute to the design of upcoming clinical trials

13. Potential impact and implications of the project's findings

14. Qualifications and expertise of the research team

15. Budget and justification for requested funding

16. Current and pending support for the project

17. Compliance with ethical considerations and protection of human subjects, if applicable

18. References and citations to support the proposed research

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows